JANX - Janux Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.57
DETAILS
HIGH:
$45.00
LOW:
$14.00
MEDIAN:
$30.00
CONSENSUS:
$28.57
UPSIDE:
96.76%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 79.7% |
| EBIT Margin | -1136.2% |
| EBITDA Margin | -1116.0% |
| Operating Margin | -1576.7% |
| Pretax Margin | -1136.2% |
| Cont. Ops Margin | -1136.2% |
| Net Margin | -1136.2% |
| Bottom Line Margin | -1136.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 39.04 |
| Quick Ratio | 39.04 |
| Solvency Ratio | -2.201 |
| Cash Ratio | 2.09 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-7.53
Peers avg: 19.8
|
| PEG Ratio | -0.18 |
| Forward PEG | -0.18 |
| Price/Book | 0.89 |
| Price/Sales | 85.51 |
| Price/FCF | -10.27 |
| Price/Op Cash Flow | -10.40 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0220 |
| Debt/Equity | 0.0231 |
| Debt/Capital | 0.0226 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.05 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.01 |
| Operating Cash Flow Ratio | -3.290 |
| Operating Cash Flow/Sales | -822.3% |
| Free Cash Flow/Operating Cash Flow | 101.3% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -46.63 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -34.36 |
| Operating Cash Flow Coverage | -3.71 |
| Capital Expenditure Coverage | -78.84 |
| Dividend + Capital Expenditure Coverage | -78.84 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.16 |
| EPS | -1.834 |
| Debt/Share | 0.3573 |
| Cash/Share | 15.60 |
| Book Value/Share | 15.44 |
| Tangible BV/Share | 15.44 |
| Equity/Share | 15.44 |
| Operating Cash Flow/Share | -1.327 |
| Capital Expenditure/Share | 0.017 |
| FCF/Share | -1.344 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.721 |
| Price/Fair Value | 0.89 |
| Debt/Market Cap | 0.0028 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -7.39 |